Search results for "Screen"

showing 10 items of 1374 documents

Saponins from the Roots of Nylandtia spinosa

2007

From the roots of Nylandtia spinosa, four new triterpene saponins, 3- O-beta- d-glucopyranosylpresenegenin 28- O-beta- d-galactopyranosyl-(1-->4)-[alpha- l-arabinopyranosyl-(1-->3)]-beta- d-xylopyranosyl-(1-->4)-[beta- d-apiofuranosyl-(1-->3)]-alpha- l-rhamnopyranosyl-(1-->2)-beta- d-fucopyranosyl ester ( 1), 3- O-beta- d-glucopyranosylpresenegenin 28- O-beta- d-galactopyranosyl-(1-->4)-[alpha- l-arabinopyranosyl-(1-->3)]-beta- d-xylopyranosyl-(1-->4)-alpha- l-rhamnopyranosyl-(1-->2)-beta- d-fucopyranosyl ester ( 2), 3- O-beta- d-glucopyranosylpresenegenin 28- O-beta- d-apiofuranosyl-(1-->4)-[beta- d-galactopyranosyl-(1-->2)]-beta- d-xylopyranosyl-(1-->4)-alpha- l-rhamnopyranosyl-(1-->2)-be…

Nylandtia spinosaCoumaric AcidsSpermidineStereochemistrySaponinPharmaceutical SciencePharmacognosyPlant RootsAnalytical ChemistryInhibitory Concentration 50TriterpeneDrug DiscoveryHumansNuclear Magnetic Resonance BiomolecularPharmacologychemistry.chemical_classificationPlants MedicinalMolecular StructureChemistryOrganic ChemistryGlycosideTenuifolinSaponinsTriterpenesTerpenoidPolygalaceaeHuman colon cancerComplementary and alternative medicineMolecular MedicineDrug Screening Assays AntitumorJournal of Natural Products
researchProduct

Immunoanalytical methods for ochratoxin A monitoring in wine and must based on innovative immunoreagents.

2020

Immunochemical methods are highly deployed in analytical laboratories worldwide for monitoring the incidence of mycotoxins in the food chain. Nevertheless, most conventional immunoassays for ochratoxin A (OTA), including commercial kits, show limitations to robustly determine this mycotoxin in grape-derived products below regulated levels (2 ng/mL). Herein, two rapid tests for sensitive OTA determination in wine and must were developed capitalizing on a collection of bioconjugates from innovative synthetic haptens and monoclonal antibodies with subnanomolar affinity. The ELISA (LOD = 8 pg/mL) showed excellent performance in recovery studies, and it was applied to survey commercial wines and…

Ochratoxin AMonoclonal antibodyFood ContaminationWine01 natural sciencesAnalytical ChemistryFood safetychemistry.chemical_compound0404 agricultural biotechnologyLimit of DetectionScreening methodDipstickMycotoxinWineImmunoassayMycotoxinChromatographybusiness.industry010401 analytical chemistryfood and beverages04 agricultural and veterinary sciencesGeneral MedicineDipstickContaminationFood safety040401 food scienceOchratoxins0104 chemical sciencesHaptenchemistryCompetitive immunoassayCompetitive immunoassayEnvironmental scienceIndicators and ReagentsbusinessFood AnalysisFood ScienceFood chemistry
researchProduct

Knowledge and attitudes of general population belonging to pharmacies of the Province of Palermo regarding the colorectal carcinoma screening: Result…

2020

Colorectal cancer (CC) is one of the leading cause of deaths every year. Oncological screening are health and social intervention that aims to diagnose a disease in an early stage. Although the high sensitivity and specificity of the colorectal cancer screening (CCS), the adherence in the Southern Italian Administrative Regions is low. A cross-sectional study on a sample of subjects belonging to five pharmacies located in the Province of Palermo, Italy, was conducted between June 2019 and February 2020 in order to evaluate knowledge and attitudes of general population regarding CC and CCS. A higher knowledge score among population interviewed was significantly associated with residency in P…

Oncological screeningKnowledgeAttitudeAdherenceColorecatl cancer screeningColorectal cancer
researchProduct

Neoadjuvant therapy for breast cancer

2019

Objective: To evaluate the frequency of neoadjuvant therapy (NT) in women with stage I–III breast cancer in Italy and whether it is influenced by biological characteristics, screening history, and geographic area. Methods: Data from the High Resolution Study conducted in 7 Italian cancer registries were used; they are a representative sample of incident cancers in the study period (2009–2013). Included were 3546 women aged <85 years (groups <50, 50–69, 70–64, and 75+) with stage I–III breast cancer at diagnosis who underwent surgery. Women were classified as receiving NT if they received chemotherapy, target therapy, and/or hormone therapy before the first surgical treatment. Logistic…

OncologyAdultCancer Researchmedicine.medical_specialtymedicine.medical_treatmentBreast NeoplasmsSettore MED/42 - Igiene Generale E Applicata03 medical and health sciences0302 clinical medicineBreast cancerBreast cancerInternal medicineCancer screeningmedicineBiomarkers TumorOdds RatioMammographyHumans030212 general & internal medicineneoadjuvant therapyNeoadjuvant therapyTriple-negative breast cancerTumor markerCancer stagingAgedNeoplasm StagingAged 80 and overmedicine.diagnostic_testGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapyCancer registryTreatment OutcomeOncology030220 oncology & carcinogenesisFemalemultidisciplinaryMammography
researchProduct

Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?

2016

Objectives To better understand the influence of prostate-specific antigen (PSA) screening and other health system determinants on prognosis of prostate cancer, up-to-date relative survival (RS), stage distributions, and trends in survival and incidence in Germany were evaluated and compared with the United States of America (USA). Patients and methods Incidence and mortality rates for Germany and the USA for the period 1999-2010 were obtained from the Centre for Cancer Registry Data at the Robert Koch Institute and the USA Surveillance Epidemiology and End Results (SEER) database. For analyses on stage and survival, data from 12 population-based cancer registries in Germany and from the SE…

OncologyAdultMalemedicine.medical_specialtyAdolescentUrologyPopulation03 medical and health sciencesProstate cancerYoung Adult0302 clinical medicineAge DistributionPredictive Value of TestsResidence CharacteristicsInternal medicineGermanymedicineSurveillance Epidemiology and End ResultsHumansMass Screening030212 general & internal medicineeducationMass screeningAgedNeoplasm Stagingeducation.field_of_studyRelative survivalbusiness.industryMortality rateIncidence (epidemiology)IncidenceProstatic NeoplasmsReproducibility of ResultsMiddle AgedProstate-Specific Antigenmedicine.diseasePrognosisUnited StatesCancer registry030220 oncology & carcinogenesisbusinessDemographySEER ProgramBJU international
researchProduct

Distribution of human papillomavirus types in women from Valencia, Spain, with abnormal cytology.

2010

Objective To determine human papillomavirus (HPV) types among cervical smears using polymerase chain reaction (PCR) and to contribute to the knowledge of human papillomavirus genotype distribution and prevalence of oncogenic types in cervical lesions in Spain. Study Design Consensus PCR and direct sequencing of PCR products (DNA HPV typing) were used in a retrospective study to determinate the type or types of HPV on 974 cytology smears of women with abnormal cytology results. Results Of 974 smears, 79.8% were high-risk (H-R) HPVs, 19.7% low-risk (L-R) HPVs, 4.6% indeterminate-risk (I-R) HPVs, considering both single and multiple infections. Multiple infections were detected in 4.7% of the …

OncologyAdultmedicine.medical_specialtyHistologyGenotypeCost effectivenessPopulationPrevalenceUterine Cervical NeoplasmsAlphapapillomavirusCervical intraepithelial neoplasiaPolymerase Chain ReactionPathology and Forensic MedicineGene FrequencyCytologyInternal medicineGenotypemedicinePrevalenceHumansMass ScreeningeducationMass screeningRetrospective StudiesGynecologyVaginal Smearseducation.field_of_studyHuman papillomavirus 16Human papillomavirus 18business.industryPapillomavirus Infectionsvirus diseasesGeneral Medicinemedicine.diseaseUterine Cervical Dysplasiafemale genital diseases and pregnancy complicationsSquamous intraepithelial lesionSpainDNA ViralFemalebusinessActa cytologica
researchProduct

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study

2021

Anàlisi de seqüències d'ADN; Subtipus PAM50; Genètica molecular Análisis de secuencias de ADN; Subtipo PAM50; Genética molecular DNA sequence analyses; PAM50 subtype; Molecular genetic Background: The SOLTI-1301 AGATA study aimed to assess the feasibility of a multi-institutional molecular screening program to better characterize the genomic landscape of advanced breast cancer (ABC) and to facilitate patient access to matched-targeted therapies in Spain. Methods: DNA sequencing of 74 cancer-related genes was performed using FFPE tumor samples in three different laboratories with three different gene panels. A multidisciplinary advisory board prospectively recommended potential targeted trea…

OncologyCancer ResearchDNA Alterationmedicine.medical_specialtymolecular targeted therapyAdvanced breast:Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES]Cancer therapy:terapéutica::farmacoterapia::terapia molecular selectiva [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]:Therapeutics::Drug Therapy::Molecular Targeted Therapy [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]Breast cancerbreast cancerInternal medicineGene panelmolecular geneticmedicineDNA sequence analysesRC254-282Original ResearchFarmacologia molecular:neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES]:Natural Science Disciplines::Biological Science Disciplines::Biology::Computational Biology::Genomics [DISCIPLINES AND OCCUPATIONS]Molecular screeningbusiness.industryCancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseOncologyMama - Càncer - Tractament:disciplinas de las ciencias naturales::disciplinas de las ciencias biológicas::biología::biología computacional::genómica [DISCIPLINAS Y OCUPACIONES]Mama - Càncer - Aspectes molecularsPAM50 subtypebusiness
researchProduct

The influence of socio-economic and surveillance characteristics on breast cancer survival: a French population-based study.

2008

International audience; Survival data on female invasive breast cancer with 9-year follow-up from five French cancer registries were analysed by logistic regression for prognostic factors of cancer stage. The Kaplan-Meier method and log-rank test were used to estimate and compare the overall survival probability at 5 and 7 years, and at the endpoint. The Cox regression model was used for multivariate analysis. County of residence, age group, occupational status, mammographic surveillance, gynaecological prevention consultations and the diagnosis mammography, whether within a screening framework or not, were independent prognostic factors of survival. Moreover, for the same age group, and on…

OncologyCancer ResearchEpidemiologyMESH : AgedMESH : Breast NeoplasmsLogistic regressionsurvival analysis0302 clinical medicineMESH: Aged 80 and overMESH : Population SurveillanceMESH : Socioeconomic FactorsMedicineMESH : Female030212 general & internal medicineAged 80 and overMESH: AgedMESH: Middle Agedmedicine.diagnostic_testCarcinoma Ductal Breast[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieMESH: European Continental Ancestry GroupMESH: Follow-Up StudiesMiddle AgedMESH : AdultMESH : Survival Rate3. Good healthSurvival RateOncology030220 oncology & carcinogenesisPopulation SurveillanceFemalemass screeningAdultmedicine.medical_specialtyMESH: Socioeconomic FactorsMESH: Survival RatemammographyMESH: MammographyBreast NeoplasmsWhite PeopleMESH: Population SurveillanceMESH : European Continental Ancestry Group03 medical and health sciencesBreast cancerbreast neoplasmInternal medicineMammographyHumansMESH : MammographyMESH : Middle AgedMESH: Mass ScreeningMESH : Aged 80 and overSurvival rateMass screeningSurvival analysisAgedGynecologyMESH : Mass ScreeningMESH: Humansbusiness.industryProportional hazards modelMESH : HumansMESH : Carcinoma Ductal BreastCancerMESH: AdultMESH : Follow-Up Studiesmedicine.diseaseMESH: Carcinoma Ductal BreastSocioeconomic Factors[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologiesocio-economic factors[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessMESH: FemaleMESH: Breast NeoplasmsFollow-Up Studies
researchProduct

Participation in cervical cancer screening in Germany.

2010

OncologyCervical cancerAdultmedicine.medical_specialtyEpidemiologybusiness.industryPublic Health Environmental and Occupational HealthUterine Cervical NeoplasmsMiddle AgedCervical cancer screeningmedicine.diseaseYoung AdultInternal medicineGermanymedicineHumansMass ScreeningFemalePatient ParticipationbusinessAgedPreventive medicine
researchProduct

Distinct Mutational Profile of Lynch Syndrome Colorectal Cancers Diagnosed under Regular Colonoscopy Surveillance

2021

Regular colonoscopy even with short intervals does not prevent all colorectal cancers (CRC) in Lynch syndrome (LS). In the present study, we asked whether cancers detected under regular colonoscopy surveillance (incident cancers) are phenotypically different from cancers detected at first colonoscopy (prevalent cancers). We analyzed clinical, histological, immunological and mutational characteristics, including panel sequencing and high-throughput coding microsatellite (cMS) analysis, in 28 incident and 67 prevalent LS CRCs (n total = 95). Incident cancers presented with lower UICC and T stage compared to prevalent cancers (p &lt

OncologyColorectal cancerColonoscopybiomarkkeritHEREDITARYGUIDELINESTp53 mutationmedicine.disease_causeMolecular level0302 clinical medicineRISKincident cancercancer preventionmedicine.diagnostic_testRGeneral MedicineTUMORSLynch syndrome3. Good healthsyöpäsolutCARCINOMAS030220 oncology & carcinogenesisMedicineDNA mismatch repair030211 gastroenterology & hepatologyKRAScarcinogenesiskoloskopiamedicine.medical_specialtyDATABASEcolorectal cancersuolistosyövätmikrosatelliititArticle03 medical and health sciencescolonoscopy screeningInternal medicinemutational profilingmedicineLynchin oireyhtymäPathologicalpaksusuolisyöpäCancer preventionmismatch repair deficiencybusiness.industryMicrosatellite instabilitySCREENING INTERVAL3126 Surgery anesthesiology intensive care radiologymedicine.diseasedigestive system diseasesMSH2Lynch syndromeMSH23121 General medicine internal medicine and other clinical medicineT-stageCLINICAL MANAGEMENTmicrosatellite instabilitymutaatiotbusinessJournal of Clinical Medicine
researchProduct